Richard Fessler, MD, PhD, of Northwestern University and Northwestern Memorial Hospital in Chicago, is leading the first clinical trial testing the safety of embryonic stem cells in humans, according to a Reuters report.
Currently, only two facilities are open for patient enrollment in the clinical trial: Shephard Center in Atlanta, Ga., and Northwestern Memorial Hospital in Chicago. Patients interested in participating in the trial will undergo tremendously strict selection processes, and in the end, only eight will participate.
The trial is sponsored by Geron Corp., a biopharmaceutical company, which has the first U.S. FDA license to use embryonic stem cells to treat people. More specifically, Geron is using the stem cells on patients with new spinal cord injuries.
Read the Reuters report about Northwestern's stem cell trial.
Read more about Northwestern Memorial Hospital:
-Chicago Area Hospitals Prepare for Rulings on Tax-Exempt Status
-Northwestern Memorial Hospital, Physicians to Become Northwestern Medicine
-Hospital Leader to Know: Dean Harrison of Northwestern Memorial Healthcare
Currently, only two facilities are open for patient enrollment in the clinical trial: Shephard Center in Atlanta, Ga., and Northwestern Memorial Hospital in Chicago. Patients interested in participating in the trial will undergo tremendously strict selection processes, and in the end, only eight will participate.
The trial is sponsored by Geron Corp., a biopharmaceutical company, which has the first U.S. FDA license to use embryonic stem cells to treat people. More specifically, Geron is using the stem cells on patients with new spinal cord injuries.
Read the Reuters report about Northwestern's stem cell trial.
Read more about Northwestern Memorial Hospital:
-Chicago Area Hospitals Prepare for Rulings on Tax-Exempt Status
-Northwestern Memorial Hospital, Physicians to Become Northwestern Medicine
-Hospital Leader to Know: Dean Harrison of Northwestern Memorial Healthcare